I

Indaptus Therapeutics
D

INDP

1.12000
USD
-0.06
(-5.08%)
مغلق
حجم التداول
105
الربح لكل سهم
0
العائد الربحي
0
P/E
-1
حجم السوق
11,420,510
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: Indaptus Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.